Get started
Author

Lea Pöschmann

Health-related quality of life and symptom burden in patients with melanoma during and after immune checkpoint inhibitor therapy – a pilot study
2025 · Lea Pöschmann, Friedegund Meier, et al. · BMC Cancer · 4
PDF
Living with melanoma: a study protocol for the design and participatory development of a survivorship care programme for people with metastatic melanoma
2026 · Madlen Hörold, Karl Philipp Drewitz, et al. · Skin Health and Disease · 1
Herausforderungen von Melanom-Patient:innen im Kontext gesundheitsbezogener Lebensqualität
2026 · Hörold, Madlen, Küster, Benjamin, et al. · German Medical Science (German Research Foundation)
Correction: 1H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis
2026 · Frank Friedrich Gellrich, Cosima Hufnagel, et al. · Scientific Reports
PDF
Earlier detection of melanoma using in vivo reflectance confocal microscopy—a retrospective analysis
2026 · Lea Pöschmann, Pauline Waibel, et al. · Frontiers in Medicine
PDF
Phase A: Design and participatory development of a survivorship care program for people with stage III or IV metastatic melanoma.
2026 · Lea Pöschmann, Christian Apfelbacher, et al. · OSF Preprints (OSF Preprints)
¹H-NMR serum metabolomic profiling from clinical routine identifies signatures of progressive melanoma metastasis
2026 · Frank Friedrich Gellrich, Cosima Hufnagel, et al. · Scientific Reports
PDF
Neurological adverse events related to immune checkpoint inhibitor therapy in skin cancer patients - a monocentric retrospective analysis
2026 · L. Pöschmann, F. Meier, et al. · EJC Skin Cancer
Living with melanoma: A study protocol for the design and participatory development of a survivorship care program for people with melanoma
2026 · Hörold, Madlen, Drewitz, Karl-Philipp, et al.
Works count: 15
Citation count: 6
H-index: 1
I10-index:
Year
Topic
Type